6505--Radioactive (Xofigo) Isotopes Notice of Intent to Sole Source
ID: 36C25624Q0041Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF256-NETWORK CONTRACT OFFICE 16 (36C256)RIDGELAND, MS, 39157, USA

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    Special Notice: VETERANS AFFAIRS, DEPARTMENT OF intends to negotiate a sole source Firm-Fixed Price contract for the procurement of Radioactive (Xofigo) Isotopes- RADIUM RA 223 DICHLORIDE INJECTION for the Michael E. DeBakey VA Medical Center located in Houston, Texas with Cardinal Health, Inc. This service is typically used for medical purposes at the VA Medical Center.

    Point(s) of Contact
    Jeneice MatthewsContract Specialist
    713-791-1414 ext. 44002
    jeneice.matthews@va.gov
    Files
    Title
    Posted
    Lifecycle
    Title
    Type
    Similar Opportunities
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6515--LEAD LINED CONTAINERS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of lead-lined containers and associated radiation protection equipment for the new Fredericksburg Health Care Center. The specific items required include a Standard L-Block Shield, a Lead Lined Sharps Container, and a Lead Brick Enclosure, all aimed at enhancing safety measures in handling hazardous materials in nuclear medicine. This procurement is part of a 100% small business set-aside initiative, with offers due by January 17, 2025, at 10:00 am EST, and delivery expected between December 1, 2024, and February 1, 2025. Interested vendors can contact Contract Specialist Natasha M Hawkins at Natasha.Hawkins@va.gov for further details.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    R420--Copy of Amarillo Commission on Cancer
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole-source contract to the American College of Surgeons for accreditation services related to the Veterans Affairs Cancer Program (VACP) under the Commission on Cancer (CoC). This firm-fixed price contract will cover the period from February 28, 2025, to February 27, 2026, as the American College of Surgeons is the only organization capable of providing this national accreditation. This procurement is crucial for ensuring the quality and compliance of cancer care services within the VA system. Interested parties may submit capability statements within seven days of the notice publication; otherwise, the contract will proceed without further notice. For inquiries, contact Contract Specialist Gillian Hooge at gillian.hooge@va.gov or (210) 364-3724.
    6505--761-25-1-015-0001 -Chelmsford CMOP Pharm -(VA-25-00012051)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for various pharmaceutical products to be supplied to the Chelmsford VA Center facility. The procurement includes items such as a vaginal gel, multivitamin tablets, and a wound therapy solution, with specific quantities and packaging requirements outlined for each product. This solicitation underscores the VA's commitment to ensuring a stable supply of essential medications for veterans while adhering to federal procurement regulations. Interested vendors must submit their quotations by January 17, 2025, and provide necessary documentation, including a state wholesale distributor license and OEM authorization, to the designated contract specialist, Lacie Nowak, at Lacie.nowak@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0109 770-25-2-801-0180 -National CMOP SEVELAMER CARBONATE 800MG
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement of Sevelamer Carbonate 800mg tablets for delivery to multiple CMOP facilities. The solicitation requires vendors to provide detailed quotes in Excel format, including compliance with the Drug Supply Chain Security Act and adherence to the Buy American statute, which emphasizes the preference for U.S.-made products. This procurement is critical for ensuring the availability of essential pharmaceuticals to support the healthcare needs of veterans. Interested vendors must submit their quotes by January 13, 2025, with the anticipated award date set for January 16, 2025; for further inquiries, contact Michael W McAlhaney at Michael.McAlhaney@va.gov or call (913) 684-0134.
    Bicalutamide 50MG tablets
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is issuing a solicitation for a national requirements contract for Bicalutamide 50MG tablets, available in bottle counts of 30 and 500. The procurement aims to establish a reliable supply source for these pharmaceutical items, which are critical for various Department of Defense and other federal health programs, including the Department of Veterans Affairs and the Indian Health Service. This unrestricted and fully competitive acquisition will be a firm-fixed price contract with a one-year base and four one-year options, with proposals due by January 24, 2025. Interested parties can reach out to Keith Ryales at keith.ryales@dla.mil or 215-737-9199 for further inquiries and are encouraged to monitor the DLA Bid Board System and SAM.gov for updates on the solicitation.
    6550--VISN 12 Ortho Vision Reagents and Service INTENT TO SOLE SOURCE POSTING
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Great Lakes Acquisition Center, intends to negotiate a sole source contract with Ortho Clinical Diagnostics for the provision of blood bank reagents and consumable supplies. These supplies must be FDA 510(k) cleared for use on government-owned Ortho Vision Swift Analyzers, which are utilized across facilities in Wisconsin, Illinois, and Michigan. This procurement is critical for ensuring the effective operation of laboratory services within the Veterans Health Administration, adhering to FAR 6.302-1, which allows for a sole source contract when only one responsible source can meet the agency's needs. Interested firms that believe they can fulfill these requirements are encouraged to submit supporting evidence and references to the Contracting Officer, Teresa Beers, at teresa.beers@va.gov or via fax at (414) 844-4888 within seven calendar days of this notice. If no responses are received, the VA will proceed with negotiations with Ortho Clinical Diagnostics.